Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Cellebrite DI Ltd (NASDAQ: CLBT) closed the day trading at $16.55 down -0.78% from the previous closing price of $16.68. In other words, the price has decreased by -$0.78 from its previous closing price. On the day, 0.76 million shares were traded. CLBT stock price reached its highest trading level at $16.87 during the session, while it also had its lowest trading level at $16.4.
Ratios:
For a better understanding of CLBT, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 19.28 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 37.99. For the most recent quarter (mrq), Quick Ratio is recorded 1.69 and its Current Ratio is at 1.73.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on March 28, 2024, Reiterated its Buy rating but revised its target price to $13.50 from $13 previously.
BofA Securities Upgraded its Neutral to Buy on February 16, 2024, whereas the target price for the stock was revised from $9 to $12.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 16 ’24 when YOSEF CARMIL bought 100,000 shares for $17.51 per share.
Ben-Peretz Leeor bought 8,919 shares of CLBT for $151,177 on Sep 04 ’24. On Aug 28 ’24, another insider, Carmil Yosef, who serves as the Officer of the company, bought 37,103 shares for $17.40 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLBT now has a Market Capitalization of 3555651584 and an Enterprise Value of 3142710272. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.50. Its current Enterprise Value per Revenue stands at 8.67 whereas that against EBITDA is 51.554.
Stock Price History:
Over the past 52 weeks, CLBT has reached a high of $17.82, while it has fallen to a 52-week low of $6.36. The 50-Day Moving Average of the stock is 5.15%, while the 200-Day Moving Average is calculated to be 38.26%.
Shares Statistics:
Over the past 3-months, CLBT traded about 1.38M shares per day on average, while over the past 10 days, CLBT traded about 961870 shares per day. A total of 203.23M shares are outstanding, with a floating share count of 61.31M. Insiders hold about 70.54% of the company’s shares, while institutions hold 33.49% stake in the company. Shares short for CLBT as of 1726185600 were 3251725 with a Short Ratio of 2.35, compared to 1723680000 on 3014638. Therefore, it implies a Short% of Shares Outstanding of 3251725 and a Short% of Float of 3.1.
